240 related articles for article (PubMed ID: 19406930)
21. Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades.
Sun HN; Kim SU; Huang SM; Kim JM; Park YH; Kim SH; Yang HY; Chung KJ; Lee TH; Choi HS; Min JS; Park MK; Kim SK; Lee SR; Chang KT; Lee SH; Yu DY; Lee DS
J Neurochem; 2010 Jul; 114(1):39-50. PubMed ID: 20345759
[TBL] [Abstract][Full Text] [Related]
22. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
Lee HH; Jeong JW; Lee JH; Kim GY; Cheong J; Jeong YK; Yoo YH; Choi YH
Oncol Rep; 2013 Sep; 30(3):1257-64. PubMed ID: 23828231
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
24. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
25. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
[TBL] [Abstract][Full Text] [Related]
27. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
28. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis.
Guicciardi ME; Bronk SF; Werneburg NW; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1337-46. PubMed ID: 17272514
[TBL] [Abstract][Full Text] [Related]
29. Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun/AP-1 signaling pathway.
Jin CY; Park C; Hong SH; Han MH; Jeong JW; Xu H; Liu H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):321-8. PubMed ID: 23582782
[TBL] [Abstract][Full Text] [Related]
30. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells.
Zhang M; Harashima N; Moritani T; Huang W; Harada M
PLoS One; 2015; 10(5):e0127386. PubMed ID: 26000607
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
Lim SC; Choi JE; Kang HS; Han SI
Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
[TBL] [Abstract][Full Text] [Related]
32. Induction of hepatoma carcinoma cell apoptosis through activation of the JNK-nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-ROS self-driven death signal circuit.
Zeng KW; Song FJ; Wang YH; Li N; Yu Q; Liao LX; Jiang Y; Tu PF
Cancer Lett; 2014 Oct; 353(2):220-31. PubMed ID: 25064608
[TBL] [Abstract][Full Text] [Related]
33. Elevated Pressure Enhanced Trail-Induced Apoptosis in Hepatocellular Carcinoma Cells Via Erk1/2-Inactivation.
Hong E; Lee E; Kim J; Kwon D; Lim Y
Cell Mol Biol Lett; 2015 Dec; 20(4):535-48. PubMed ID: 26124051
[TBL] [Abstract][Full Text] [Related]
34. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
35. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
36. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
[TBL] [Abstract][Full Text] [Related]
37. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
[TBL] [Abstract][Full Text] [Related]
38. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells.
Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH
Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975
[TBL] [Abstract][Full Text] [Related]
39. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase.
Chen Q; Li W; Quan Z; Sumpio BE
J Vasc Surg; 2003 Mar; 37(3):660-8. PubMed ID: 12618707
[TBL] [Abstract][Full Text] [Related]
40. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
